General content related to epidemiology, with links to Barker or Coffey lab sites as relevant.
CDC Info on Zika
- Zika Cases in the United States
- Congenital Zika Syndrome and Other Birth Defects
- Clinical Considerations for Pregnant Women with Possible Zika Virus Infection | Zika Virus | CDC
- Testing for Zika
- Preventing Zika
- How Zika Spreads
- Zika Symptoms and Complications
- Protecting Workers from Zika
- Work outdoors? Protect yourself!
- Know before you go!
Zika virus Articles:
- Environmental factors associated with microcephaly in Africa: A systematic review
- Targeting Yellow-Fever Virus: Development of a specific aptamer to NS1 protein
- Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
- Zika virus exacerbates EAE by inducing the production of T cell-attracting chemokines in astrocytes
- Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy
- Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil, 2019-2021
- The TH1/TH2 Response Imbalance Zika Virus Pathogenesis: An Immunological Paradox
- Comparison of human cerebral organoids infected with wild-type Zika versus attenuated DN-2 virus strains uncovers differences in host immune responses
- Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates
- Vector competence of Aedes albopictus and Aedes aegypti from the islands of the Southwestern Indian Ocean for epidemic Zika, dengue, and chikungunya viruses
Latest on Zika virus
- Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface
- The TH1/TH2 Response Imbalance Zika Virus Pathogenesis: An Immunological Paradox
- Zika virus exacerbates EAE by inducing the production of T cell-attracting chemokines in astrocytes
- Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy
- Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil, 2019-2021
Latest on dengue virus
- Dengue virus infection and Guillain-Barre syndrome: a systematic review of clinical characteristics, outcomes, and predictors of severity
- Identifying high-risk subdistricts for targeted dengue interventions: a spatio-temporal study in Mueang Chonburi district, Thailand, 2011-2020
- A Case of Severe Dengue With Hemophagocytic Lymphohistiocytosis (HLH) Successfully Managed With Tocilizumab and Dexamethasone
- Neonatal outcomes associated with maternal arbovirus infection (dengue, Zika, and chikungunya) among pregnant women with obstetric complications in Brazil: a cross-sectional study
- Functional dynamics between resident transcriptionally active microbes (TAMs) and host genes underlie Dengue severity